This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity for February 2025, including long-awaited proposed and ...

Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data ...

The Hatch Waxman Act and the Biological Price Competition and Innovation Act have incentivized efforts to improperly prolong ...

The team found that the U.S. Food and Drug Administration (FDA)-approved drug sevelamer, typically prescribed to help bind excess phosphorus in the blood of people with chronic kidney disease ...

According to Satsuma Pharmaceuticals, the dry powder DHE formulation is expected to provide fast absorption and robust efficacy compared with existing DHE products. The Company is seeking approval for ...

BBVA SA plans to offer retail clients in Spain access to cryptocurrencies, after receiving regulatory approval from market supervisor CNMV to provide custody and execution services for such assets.

M&G Investments has received regulatory approval from the Financial Conduct Authority for the launch of its first long-term asset fund (LTAF). The M&G Diversified Private Credit Feeder LTAF will be ...

Over the past decade and a half, the financial services industry has been subject to an increasing array of regulatory requirements as policymakers sought to restore financial stability and ...

With Spain now entering the fold, BBVA is broadening its crypto services in line with evolving European regulations ... July 2026 to fully comply with its requirements under an 18-month ...

Ohio tried to implement work requirements for the Medicaid expansion group prior to the COVID-19 pandemic after the state received approval from CMS during President Donald Trump’s first term in ...

Spanish bank BBVA has received regulatory approval to offer Bitcoin and Ethereum trading to clients Approval comes as EU’s MiCA regulation takes full effect across the European Union This concludes ...

If you have a loved one with Alzheimer’s disease, you may have read about a newly approved drug. And you may have heard that the drug has caused some controversy. So, what’s really going on?